NDC 12634-437

Carisoprodol

Carisoprodol

Carisoprodol is a Oral Tablet in the Human Prescription Drug category. It is labeled and distributed by Apotheca Inc.. The primary component is Carisoprodol.

Product ID12634-437_29dc4824-73b8-600e-e054-00144ff8d46c
NDC12634-437
Product TypeHuman Prescription Drug
Proprietary NameCarisoprodol
Generic NameCarisoprodol
Dosage FormTablet
Route of AdministrationORAL
Marketing Start Date1991-10-17
Marketing CategoryANDA / ANDA
Application NumberANDA089346
Labeler NameApotheca Inc.
Substance NameCARISOPRODOL
Active Ingredient Strength350 mg/1
Pharm ClassesCentrally-mediated Muscle Relaxation [PE],Muscle Relaxant [EPC]
DEA ScheduleCIV
NDC Exclude FlagE
Listing Certified Through2017-12-31

Packaging

NDC 12634-437-00

10 TABLET in 1 BOTTLE, PLASTIC (12634-437-00)
Marketing Start Date1991-10-17
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 12634-437-91 [12634043791]

Carisoprodol TABLET
Marketing CategoryANDA
Application NumberANDA089346
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date1991-10-17
Inactivation Date2020-01-31

NDC 12634-437-00 [12634043700]

Carisoprodol TABLET
Marketing CategoryANDA
Application NumberANDA089346
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2016-01-21
Inactivation Date2020-01-31

NDC 12634-437-01 [12634043701]

Carisoprodol TABLET
Marketing CategoryANDA
Application NumberANDA089346
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2016-01-21
Inactivation Date2020-01-31

NDC 12634-437-74 [12634043774]

Carisoprodol TABLET
Marketing CategoryANDA
Application NumberANDA089346
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2016-01-21
Inactivation Date2020-01-31

NDC 12634-437-85 [12634043785]

Carisoprodol TABLET
Marketing CategoryANDA
Application NumberANDA089346
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date1991-10-17
Inactivation Date2020-01-31

NDC 12634-437-95 [12634043795]

Carisoprodol TABLET
Marketing CategoryANDA
Application NumberANDA089346
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2016-01-21
Inactivation Date2020-01-31

NDC 12634-437-96 [12634043796]

Carisoprodol TABLET
Marketing CategoryANDA
Application NumberANDA089346
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2016-01-21
Inactivation Date2020-01-31

NDC 12634-437-79 [12634043779]

Carisoprodol TABLET
Marketing CategoryANDA
Application NumberANDA089346
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2010-07-05
Inactivation Date2020-01-31

NDC 12634-437-59 [12634043759]

Carisoprodol TABLET
Marketing CategoryANDA
Application NumberANDA089346
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date1991-10-17
Inactivation Date2020-01-31

NDC 12634-437-71 [12634043771]

Carisoprodol TABLET
Marketing CategoryANDA
Application NumberANDA089346
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date1991-10-17
Inactivation Date2020-01-31

NDC 12634-437-61 [12634043761]

Carisoprodol TABLET
Marketing CategoryANDA
Application NumberANDA089346
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date1991-10-17
Marketing End Date2016-01-21

NDC 12634-437-80 [12634043780]

Carisoprodol TABLET
Marketing CategoryANDA
Application NumberANDA089346
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2016-01-21
Inactivation Date2020-01-31

Drug Details

Active Ingredients

IngredientStrength
CARISOPRODOL350 mg/1

OpenFDA Data

SPL SET ID:7d7d44b4-d405-4c48-9e79-cc128dd7aaeb
Manufacturer
UNII
RxNorm Concept Unique ID - RxCUI
  • 197446

    • Pharmacological Class

    • Centrally-mediated Muscle Relaxation [PE]
    • Muscle Relaxant [EPC]

    NDC Crossover Matching brand name "Carisoprodol" or generic name "Carisoprodol"

    NDCBrand NameGeneric Name
    0143-1176CarisoprodolCarisoprodol
    0143-9749CarisoprodolCarisoprodol
    0591-5513CarisoprodolCarisoprodol
    0603-2582CarisoprodolCarisoprodol
    10544-033CarisoprodolCarisoprodol
    10544-088CARISOPRODOLCARISOPRODOL
    10544-132CarisoprodolCarisoprodol
    12634-437CarisoprodolCarisoprodol
    16571-780carisoprodolcarisoprodol
    16571-781carisoprodolcarisoprodol
    16714-510CarisoprodolCarisoprodol
    29033-207CarisoprodolCarisoprodol
    29033-214CarisoprodolCarisoprodol
    33261-387CarisoprodolCarisoprodol
    33358-064CARISOPRODOLCARISOPRODOL
    35356-721CarisoprodolCarisoprodol
    42254-068CarisoprodolCarisoprodol
    42543-434CARISOPRODOLCARISOPRODOL
    42543-700CARISOPRODOLCARISOPRODOL
    43063-302CarisoprodolCarisoprodol
    43063-824CarisoprodolCarisoprodol
    43353-102CARISOPRODOLCARISOPRODOL
    68071-2188CarisoprodolCarisoprodol
    68071-4263CarisoprodolCarisoprodol
    68071-4112CarisoprodolCarisoprodol
    68071-4610CARISOPRODOLCARISOPRODOL
    68387-600CarisoprodolCarisoprodol
    68788-6866CarisoprodolCarisoprodol
    68788-2582CarisoprodolCarisoprodol
    68788-9976CARISOPRODOLCARISOPRODOL
    70518-0704CarisoprodolCarisoprodol
    70518-1092CarisoprodolCarisoprodol
    70518-1401CarisoprodolCarisoprodol
    71335-0131CarisoprodolCarisoprodol
    71205-241CARISOPRODOLCARISOPRODOL
    71335-0407CarisoprodolCarisoprodol
    71335-0516CARISOPRODOLCARISOPRODOL
    71335-0693CARISOPRODOLCARISOPRODOL
    71610-097CARISOPRODOLCARISOPRODOL
    75921-513CARISOPRODOLCARISOPRODOL
    76333-135CarisoprodolCarisoprodol
    50090-0281CarisoprodolCarisoprodol
    49999-064CarisoprodolCarisoprodol
    50090-0280CarisoprodolCarisoprodol
    50090-2530CarisoprodolCarisoprodol
    50090-3232CarisoprodolCarisoprodol
    50090-3048CARISOPRODOLCARISOPRODOL
    50090-3211CarisoprodolCarisoprodol
    50090-2771CarisoprodolCarisoprodol
    50228-109CARISOPRODOLCARISOPRODOL
    © 2024 FDA.report
    This site is not affiliated with or endorsed by the FDA.